<DOC>
	<DOC>NCT00554307</DOC>
	<brief_summary>The purpose of this study is to determine how the medications which are used to close the patent ductus arteriosus (PDA) in preterm infants affect brain, kidney and gut blood flow when compared to infants that are not treated with these medications. The medications being used for PDA closure are indomethacin and neoprofen.</brief_summary>
	<brief_title>Brain, Gut and Kidney Blood Flow During Medical Closure of PDA</brief_title>
	<detailed_description>All babies requiring medical treatment of their PDA will receive up to 3 doses of medication. For babies enrolled in the control group of this study, she/he will not be treated with either of these medicines.</detailed_description>
	<mesh_term>Ductus Arteriosus, Patent</mesh_term>
	<mesh_term>Indomethacin</mesh_term>
	<criteria>Less than or equal to 32 weeks gestation; Less than or equal to 1250 g; Mechanical ventilation; Echocardiographic findings of PDA with left to right shunting; Medical judgement of neonatologist for medical treatment; Urine output less than 1 ml/k/hr over previous 12 hours; Serum creatinine greater than 1.5 mg/dL; Platelet count less than 100,000 per cubic mm; Significant skin breakdown at sensor areas; Significant congenital anomalies Intraventricular hemorrhage greater than or equal to grade III</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>patent ductus arteriosus</keyword>
	<keyword>indomethacin</keyword>
	<keyword>neoprofen</keyword>
	<keyword>blood flow</keyword>
</DOC>